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ABSTRACT 
The developmental regulation of the a-fetoprotein 
(AFP) gene in liver results in high-level expression in 
the fetus, followed by dramatic transcriptional re- 
pression after birth. We have examined the mouse AFP 
gene for transcriptional control sequences that may be 
involved in its postnatal repression in liver. We showed 
previously that removal of a DNA region between 
positions - 250 base pairs (bp) and - 838 bp of the AFP 
gene resulted in the persistence of expression of an 
AFP minigene in the postpartum liver of transgenic 
mice (Vacher and Tilghman, Science 250; 1732-1735, 
1990). This study examines the distribution of these 
transgene transcripts in liver using in situ hybrid- 
ization. We show that there is a zonal distribution of 
minigene transcripts in the adult livers of these an- 
imals. Hepatocytes surrounding the central veins ex- 
press high levels of minigene transcripts, while hepa- 
tocytes in the intermediate and portal areas contain 
few, if any, transcripts. Quantitative RNAse protection 
analysis shows a decrease in transgene RNA levels after 
birth, consistent with repression in all but a small 
subset of hepatocytes. These results indicate that 
repression in the pericentral hepatocytes is dependent 
upon the presence of a cis-acting, negative-regulatory 
domain, which is located between the enhancers and 
the proximal promoter of the AFP gene. In contrast, 
this domain is not essential for complete repression of 
AFP transgenes in the intermediate zone and peri- 
portal hepatocytes. 
COMMENTS 
a-Fetoprotein (AFP) is a 72-kD protein expressed in 
the fetal liver and yolk sac (1,2). Despite its low, almost 
undetectable levels in the adult liver, this protein has 
provoked more research and clinical interest than most 
other genes expressed in liver. AFP is detectable in 
human fetal serum at approximately 10 wk of gestation, 
about the time when endodermal cells from the ventral 
foregut meet the cardiac mesenchyma and form the liver 
primordium. In rodents, days 9.5 to 10 of gestation seem 
to  be the time at which expression of liver-specific genes 
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The albumin and AFP genes have much in common, 
including 39% overall sequence homology. Each of the 
genes encoding these two proteins in mammals exists as 
a single copy and arose from the duplication of an 
ancestral gene 300 to  500 million years ago. These genes 
remained linked throughout this period, with a 14-kb 
distance between the 3' terminus of albumin gene and 
the 5' terminus of the AFP gene (1,2,5). The expression 
of both genes is tissue specific and predominantly 
controlled at the transcriptional level. In fetal liver, 
albumin and AFP transcription seem to be activated in 
a coordinate fashion. However, after birth these two 
genes seem to be regulated independently. Thus al- 
bumin transcription increases, whereas AFP gene tran- 
scription is dramatically reduced. An approximate 
10,000-fold reduction in AFP mRNA level occurs after 
birth. Another example of independent regulation is the 
finding that AFP transcription increases during carcino- 
genesis and in the regenerating liver after toxic injury, 
whereas transcription of the albumin gene is not altered 
substantially in either condition. 
The precise function of AFP, the most abundant 
protein in fetal plasma, is not known (1, 2). There is no 
established in vivo model such as the analbuminemic rat 
with which to study whether the function of AFP is vital 
in fetal life. It has been proposed that AFP is involved in 
the maintenance of fetal oncotic pressure and in binding 
and delivery of fetal hormones, bilirubin and organic 
cations. It has also been suggested that AFP facilitates 
the immunosuppressive mechanisms that protect the 
fetoplacental unit from rejection. Despite our lack of 
comprehension of the AFP function in fetal liver, work 
on AFP gene regulation has provided important clues to 
our understanding of the tissue-specific expression of 
genes during liver development. 
After the cloning and characterization of the AFP 
gene, studies were concentrated on the characterization 
of the sequences involved in the regulation of the 
postnatal transcriptional repression of this gene (1,2,5). 
Two alternatives have been proposed to explain the 
repression phenomenon. The first assumes the presence 
of positive factorb) necessary for AFP transcription 
activation that are inactivated after birth. The second is 
the presence of a postnatal repressor or negative 
regulator of AFP transcription. To identify which of 
these alternatives is applicable to AFP gene regulation, 
Tilghman and coworkers studied the sequences in the 
AFP gene that respond to positive and negative regu- 
lators. They performed a series of experiments in which 
foreign genes containing deletions of the 5' flanking 
region of AFP were introduced into hepatoma cells. By 
comparing the transcriptional activity of each of these 
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FIG. 1. (Top) The wild-type AFP gene has three enhancers ( E l ,  E 2  and E 3 )  and a promoter (P). The region represented with a dotted line (R)  
represents an area in which repressor elements are presumed to be present. (Bottom) The constructs used to prepare transgenic mice are 
represented. A minigene containing the promoter region and a small portion of the open reading frame was created to prepare the constructs. 
Serial deletions were made at regions located between the enhancers and the minigene. ZE = construct with no deletions; A1 = construct with 
deletion from - 838 to - 604 bp; 32 = construct with a deletion from - 838 to - 250 bp; A3 = construct with a deletion from - 838 to - 118 bp. 
sequences, the authors were able to characterize three 
“enhancer” elements and a promoter. The enhancer 
elements, located 6.5,  5 and 2.5 kb upstream of the AFP 
promoter, were important for the activation of the AFP 
gene and acted in a position-and orientation-inde- 
pendent manner (Fig. 1). Studies with cell cultures have 
shown that although each of these elements is an 
important modulator of the transcriptional activity of 
the AFP gene, the enhancers do not seem to regulate 
tissue specificity. However, studies using in uitro cell 
culture systems have been limited by the use of 
transformed cells, which probably lack the normal 
cell-to-cell interactions and growth patterns. 
To circumvent these problems the same group took 
advantage of an in uivo system, the transgenic mouse 
(2). In this method, DNA constructs consisting of a 
portion of the 5’ flanking region of the gene of interest 
are attached to a promoter and a reporter gene (in this 
case, an internally deleted structural gene called a 
“minigene”). These constructs are then introduced into 
the germ line of mice. The founders are selected on the 
basis of the integration of these constructs into the 
genome and on the expression of this “transgene” in the 
tissue of interest. This technology allowed the investi- 
gators to prove that, in fetal liver, none of the three 
enhancers was crucial in the regulation of the tissue- 
specific expression of the AFP gene. However, the 
enhancers were important in activating transcription. 
The replacement of the AFP enhancers with those of the 
albumin gene did not seem to alter the inhibition of 
transcription observed after birth. Therefore these 
enhancers were not responsible for the developmental 
repression of the AFP gene. 
Using tissue culture methodology and transgenic 
mice, the same group showed that the proximal 1 kb of 
the 5’ flanking region had sequences that were respon- 
sible for the transcriptional decline of AFP after birth. 
When a region between -250 and -838 bp was 
removed, the AFP expression was not repressed in adult 
life. Transgenic lines prepared with three constructs 
carrying different deletions between - 250 and - 838 bp 
(Fig. 1) exhibited disturbances in the repression of the 
AFP mRNA. These sequences were, therefore, involved 
in the postnatal repression of AFP. These sequences 
represent the first defined repressor(s) which has a 
functional significance in uivo (2). Of interest was that 
mRNA from all three constructs was expressed in liver 
and yolk sac in fetal life, suggesting that the deleted 
sequences were not the domains responsible for the 
tissue-specific expression of the AFP gene. 
In this study, Emerson et al. expanded these obser- 
vations and provided a new dimension of AFP regulation 
in liver. Using the same transgenic lines, they examined 
the cellular distribution of the AFP mRNA in liver. 
Their results were quite interesting. Initially, using 
animals carrying a construct containing the intact AFP 
gene, the authors investigated the distribution of AFP 
mRNA at different stages of development (construct ZE 
in Fig. 1). In fetal life, AFP mRNA was homogeneously 
distributed among all hepatocytes in the liver cell plate. 
However, starting from the first postnatal week, the 
AFP mRNA was restricted to the perivenous area. Two 
weeks after birth, only one or two rows of hepatocytes 
surrounding the hepatic venule expressed AFP mRNA. 
From then on, AFP mRNA disappeared completely. 
Thus the transcriptional decline of the AFP gene in 
normal liver, as detected with in situ hybridization, 
corresponds to a decrease in the number of hepatocytes 
transcribing this gene. Furthermore, the hepatocytes 
transcribing the AFP gene were perivenular. Thus, 
there seems to be both a temporal and a hepatocyte 
position-dependent repression of the AFP gene. 
Next, the livers of the animals carrying deletions in 
this 5’ flanking region of the AFP gene ( -- 250 and - 838 
bp; A3 and A7 constructs in Fig. 1) were studied. 
Strikingly, in these experiments, one or two rows of cells 
surrounding the hepatic venule continued to express 
AFP in adult life. Thus repression of AFP in perivenular 
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cells was blocked by the deletion of this 588-bp fragment 
(-250 to -838 bp) in the AFP gene. The authors 
concluded that this sequence must contain a negative 
regulatory domain necessary and sufficient for the 
complete repression of the AFP gene transcription. 
Another interesting observation was the delay observed 
in the gradual disappearance of the AFP transcripts 
from all other hepatocytes (periportal and interme- 
diate). The animals carrying A3 constructs repressed 
AFP expression with a 4-wk delay, compared with 
animals carrying ZE constructs. This finding suggests 
that the deleted sequences in the A 3  construct have a 
complementary role in the postnatal repression of AFP 
in hepatocytes located in the periportal and intermediate 
areas in the cell plate. 
This work therefore identifies AFP as the first 
mammalian gene with intragenic repressor sequences. 
These cis-acting repressor sequences are functional only 
in a subpopulation of perivenular hepatocytes and only 
at a specific point in development. Interestingly, in 
rodents, this phase corresponds to  the completion of the 
anatomical development of liver structure and to the 
establishment of the adult pattern of expression of 
certain genes such as those involved in ammonia 
metabolism. In contrast, the hepatocytes that are not in 
a perivenular location seem to have the ability to repress 
the expression of AFP. Most likely, other sequences have 
a primary role in AFP repression in nonperivenular 
hepatocytes. 
As mentioned previously, AFP gene expression can be 
repressed by chemical injury or carcinogenesis, and the 
common denominator in these events seems to be 
induction of cell proliferation. However, AFP is not 
markedly induced in other models of cell proliferation 
such as partial hepatectomy (8, 9). In addition, agents 
such as CC1, that induce AFP cause perivenular hepa- 
tocyte damage. Therefore it is possible that AFP ex- 
pression is induced not just by cell damage or activation 
of hepatocyte proliferation but by the disappearance of 
trans-acting repressor elements located in perivenular 
hepatocytes. After CC1, damage, glutamine synthetase 
expression (as shown at the mRNA and the apoprotein 
level), disappears as soon as the perivenular cells are 
damaged (10). Expression reappears as soon as appro- 
priate cell contacts are established. It has been suggested 
that the interaction between perivenular hepatocytes 
(endoderm derived) and hepatic venule (of mesenchymal 
origin) in the perivenular area is responsible for the 
generation of signals or trans-acting elements that bind 
to the - 838 to - 250 bp sequence in AFP gene. 
It has been shown in the past decade that perivenular 
hepatocytes differ from the rest of the hepatocytes in the 
liver cell plate in several respects (6). First, perivenular 
hepatocytes are located at the end of the liver cell plate 
and thus are exposed to lower concentrations of nu- 
trients, hormones and oxygen. Second, certain genes 
are only expressed in this compartment, including 
glutamine synthetase, ornithine aminocarboxylase, and 
a2u-globulin (3, 6) .  Third, perivenular hepatocytes are 
in close proximity to the hepatic venule. It has been 
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proposed that the regulation of certain genes in these 
perivenular hepatocytes depends on cell-to-cell interac- 
tions involving the cells of the hepatic venule. This 
proposal remains to be proved. However, perivenular 
hepatocytes transplanted into the spleen lose the ability 
to transcribe glutamine synthetase when they are not in 
close proximity to vascular structures. Periportal hepa- 
tocytes, in close contact with splenic vessels, acquire the 
ability to express glutamine synthetase (7, 10). 
This article, like any other good study, raises more 
questions than it answers. The study highlights the 
importance of looking at the tissue distribution of genes 
while investigating the developmental and positional 
repression of a model gene. Future work in this area will 
improve our understanding of the position-dependent 
control of gene expression in the liver cell plate. 
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